Nutrien (NYSE:NTR) Given New $53.00 Price Target at Wells Fargo & Company

Nutrien (NYSE:NTRFree Report) had its target price lifted by Wells Fargo & Company from $52.00 to $53.00 in a research note published on Tuesday morning,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock.

Several other equities research analysts have also weighed in on NTR. Raymond James upgraded Nutrien from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $58.00 to $60.00 in a report on Tuesday, December 3rd. UBS Group downgraded shares of Nutrien from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $66.00 to $51.00 in a report on Thursday, October 10th. TD Securities lowered their target price on shares of Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a research note on Tuesday, November 12th. Piper Sandler boosted their target price on shares of Nutrien from $58.00 to $63.00 and gave the stock an “overweight” rating in a research report on Monday. Finally, Oppenheimer began coverage on Nutrien in a research note on Thursday, December 12th. They issued an “outperform” rating and a $60.00 price objective on the stock. One research analyst has rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, Nutrien presently has an average rating of “Moderate Buy” and a consensus price target of $58.94.

Get Our Latest Research Report on Nutrien

Nutrien Stock Performance

Shares of NTR opened at $52.48 on Tuesday. The firm has a market cap of $25.77 billion, a price-to-earnings ratio of 35.22, a price-to-earnings-growth ratio of 1.17 and a beta of 0.81. The company’s fifty day moving average is $47.75 and its 200-day moving average is $48.00. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. Nutrien has a 12 month low of $43.69 and a 12 month high of $60.87.

Nutrien (NYSE:NTRGet Free Report) last posted its earnings results on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.04). Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The business had revenue of $5.35 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same period in the previous year, the company earned $0.35 earnings per share. The company’s quarterly revenue was down 5.0% compared to the same quarter last year. Equities analysts expect that Nutrien will post 3.5 EPS for the current fiscal year.

Nutrien Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 17th. Shareholders of record on Tuesday, December 31st were issued a $0.939 dividend. This represents a $3.76 annualized dividend and a yield of 7.16%. The ex-dividend date was Tuesday, December 31st. This is a positive change from Nutrien’s previous quarterly dividend of $0.54. Nutrien’s payout ratio is 144.97%.

Institutional Trading of Nutrien

Several institutional investors have recently made changes to their positions in NTR. Silchester International Investors LLP raised its position in Nutrien by 9.5% in the fourth quarter. Silchester International Investors LLP now owns 11,693,137 shares of the company’s stock worth $523,268,000 after purchasing an additional 1,009,895 shares in the last quarter. ARGA Investment Management LP lifted its position in shares of Nutrien by 25.7% during the 4th quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company’s stock worth $270,396,000 after buying an additional 1,236,671 shares during the period. National Bank of Canada FI boosted its stake in Nutrien by 4.1% in the 3rd quarter. National Bank of Canada FI now owns 4,232,211 shares of the company’s stock valued at $203,380,000 after buying an additional 165,582 shares in the last quarter. Toronto Dominion Bank grew its position in Nutrien by 11.9% in the third quarter. Toronto Dominion Bank now owns 4,220,354 shares of the company’s stock valued at $202,830,000 after acquiring an additional 447,413 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Nutrien during the third quarter worth $150,181,000. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Read More

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.